1Bordignon C,Bonini C,Verzeletti S,et al.Transfer of the HSV-TK gene into donor peripheral blood lymphocytes for invo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.Hum Gene Ther,1995,6(6):813-819.
2Ohira T, Ohe Y, Heike Y, et al. Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin-2 cDNAs co-transfected subline.Gene Ther, 1994,1(4):269-275.
3Ram Z, Walbridge S, Heiss JD, et al. In vivo transfer of the human interleukin-2 gene: Negative tumoricidal results in experimental brain tumor, J Neurosurg, 1994,80(3):535-540.
4Fujiwara T,Crimm EA,Mukhopadhyay T,et al.Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene.Cancer Res,1994,54(9):2287-2291.
5Hodge JW,Abrams S,Schlom J,et al.Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 co-stimulatory molecules.Cancer Res,1994,54(21):5552-5555.
6Porgador A,Tzehoval E,Vadai E,et al.Immunotherapy via gene therapy:Comparison of the effects of tumor cells transduced with the interleukin-2,interleukin-6,or interferon-gamma genes.J Immunother, 1993,14(3):991-201.
7Mountain CF.Revisions in the international system for staging of lung cancer [J].Chest,1997,111(7):1710-1717.
8Szymanska K,Hainaut P.TP53 and mutations in human cancer [J].Acta Biochim Pol,2003,50(1):231-238.
9Hainaut P,Hollstein M.p53 and human cancer:the first ten thousand mutations [J].Adv Cancer Res,2000,77:81-137.
10Dowlatshahi K,Fan M,Bloom KJ,et al.Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma [J].Cancer,1999,86(6):990-996.
